Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers.
about
Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI).
P2860
Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Pharmacokinetic Modeling and D ...... sphatase in Healthy Volunteers
@nl
Pharmacokinetic Modeling and D ...... phatase in Healthy Volunteers.
@ast
Pharmacokinetic Modeling and D ...... phatase in Healthy Volunteers.
@en
type
label
Pharmacokinetic Modeling and D ...... sphatase in Healthy Volunteers
@nl
Pharmacokinetic Modeling and D ...... phatase in Healthy Volunteers.
@ast
Pharmacokinetic Modeling and D ...... phatase in Healthy Volunteers.
@en
prefLabel
Pharmacokinetic Modeling and D ...... sphatase in Healthy Volunteers
@nl
Pharmacokinetic Modeling and D ...... phatase in Healthy Volunteers.
@ast
Pharmacokinetic Modeling and D ...... phatase in Healthy Volunteers.
@en
P2093
P2860
P50
P3181
P1476
Pharmacokinetic Modeling and D ...... phatase in Healthy Volunteers.
@en
P2093
Andrea van Elsas
Esther Peters
Jacques Arend
Peter Pickkers
Renger Tiessen
P2860
P2888
P304
P3181
P356
10.1007/S40262-016-0399-Y
P407
P577
2016-05-04T00:00:00Z
P6179
1032304338